|
|
With Massage, Colon Hydrotherapy,
|
|
|
|
|
Home * Search for Products * View Shopping Cart * Retrieve Saved Cart |
|
|
|
Fibromyalgia & Cellfood Cellfood Concentrate could effectively provide an important contribution in the treatment of Fibromyalgia syndrome (FMS); both from chronic pain and from chronic fatigue symptoms associated with FMS. Conclusion of Study Study conducted at Universita Degli Studi Siena Efficacy of CELLFOOD (Deutrosulfazyme) in patients diagnosed with Fibromyalgia Clinical Study Introduction Fibromyalgia syndrome (FMS) is a chronic pathology characterized by widespread muscular and skeletal pain, by chronic fatigue and axial stiffness, by sleep disorder, and by tender points located in specific soft tissue and/or muscular/ skeletal areas with a variety of accompanying clinical symptoms (e.g.: Asthenia, Paraesthesia, Allodynia, Cefalea.) The diagnosis is based on a characteristic anamnesis, on the evaluation of at least 11 of 18 tender points after palpatation according to the ACR principles of 1990 and on haematic, chemical and radiographic (x-ray) exams. Fibromyalgia typically affects middle aged men and women between the ages of 30 and 55. Fibromyalgia is more prevalent in women and the outline can be primary or secondary to other chronic pathologies. Ethiopathogenesis is still not clear, but probably it presents a multi-factorial nature. In fact, neurological, neuroendocrine, psychiatric, muscular, inflammatory and genetic factors are involved. Non REM sleep troubles are common among Fibromyalgia patients and this can explain the constant asthenia upon awaking that progressively increases during the day. Some authors maintain that there is a compromise of the central and peripheral nervous system. Cellfood is a nutritional supplement in a colloidal solution based on oxygen, trace minerals, amino acids and enzymes. It eminates H+ ions (used for metabolic normalization of the acidosis) and O- ions that react with oxygen free radicals, and leads to the forming of molecular bio-available oxygen. Cellfood causes the elimination of oxygen free radicals, the conservation of
a scavenger, produces rising oxygen and provides optimal cellular nutrition. Materials and Methods Thirty (30) patients suffering from Fibromyalgia who did not respond to conventional therapies were recruited. Before the beginning of the treatment (day 0), all patinets were subjected to mechanical pain diagnostic measurements, and a subjective evaluation of critical tender points-compiled on the Fibromyalgia Impact Questionnaire (FIQ). Twenty one (21) patients were treated with Cellfood (according to the doseage suggested by NuScience Corporation) and nine (9) patients with a placebo (single blind). The protocol foresaw a control of all the above mentioned parameters 3 months before the consumption of Cellfood (day 30, and day 90). One month after the beginning, the patients were contacted by phone and a brief interview was conducted to evaluate the effectiveness of the treatment as well as the VAS on tender points (day 30). Results The following parameters as evaluated in the clinical study, showed significant improvement: VAS on actual pain (graph 1), the semi-quantitative evaluation of actual pain (graph 2), working fatigue and/or daily activity during the last week (graph 6) and the count of tender points (graph 7). The other parameters of Fibromyalgia Impact Questionnaire (FIQ) showed improvement as well, without reaching statistical significance. None of the patients experienced adverse effects connected with the products. After analyzing the clinical data, it is noted that after twelve (12) weeks of treatment with Cellfood (Deutrosulfazyme), there was a marked clinical improvement of Fibromyalgia's symptomatology both on a subjective level (VAS) and on an objective level (tender point count) on treated patients. The patients' tolerability was optimal and consequently the completion ratio was high (none of the patients withdrew from the study). In conclusion, this new therapeutic approach could effectively provide important contribution in the treatment of patients afflicted with Fibromyalgia syndrome; both from chronic pain and from chronic fatigue symptoms associated with FMS, therefore reducing the need to explore more complex pharmacological solutions. Furthermore, since the product dosage was restricted to the manufacturers suggestion , further investigation using larger dosages for a longer period of time is suggested in order to better evaluate the efficacy of the product. The following graphs are from the study conducted. They were scanned so they may not be real clear. Cellfood is the light blue color and the control is peach or pink. Please note the dramatic change in actual pain, daily activity and fatigue after 30 days of Cellfood usage.
Fibromyalgia Tender Points There are 18 tender points on the body that will usually be highly sensitive to pressure in people with fibromyalgia as specified by the American College of Rheumatology criteria. People who do not have fibromyalgia are much less tender to pressure applied at these tender points. At least 11 of the 18 specified tender points must be tender. (see diagram)
Fibromyalgia is a chronic illness that causes physical pain and
fatigue. Fibromyalgia is classified as a syndrome not a disease. Fibromyalgia's
main symptom is widespread musculoskeletal pain that affects the ligaments,
tendons, and muscles throughout the body. However, Fibromyalgia may cause many
different symptoms:
|
|
